Search Icon
SideMenu
Home
Blog

Biosimilars Council Press Releases

Blog
  • Blog

Long-Term Effects of Medicare Price Negotiations on Drug Competition
  • Blog

$423B Savings from Patent Settlements Since Actavis Ruling
  • Blog

Patent Settlements Are Necessary To Help Combat Patent Thickets
  • Blog

The IRA Hurts Generic and Biosimilar Medication Competition
  • Blog

Access! 2025 Recap: A Call to Action for the Future of Generics and Biosimilars
  • Blog

Your All ACCESS! Pass
  • Blog

Redesigned Medicare Drug Program Still Allows PBMs to Deny Patients Access to Lower-Cost Generics & Biosimilars
  • Blog

Congress Should Pass Legislation to End the Shenanigans That Allow Brand-Name Drug Manufacturers to Delay Generic Competition and Charge Higher Prices for Longer Periods
  • Blog

GRx+Biosims 2024 Conference Recap
  • Blog

Want to Save Patients Money on Medicine? No Need to Reinvent the Wheel
  • Blog

Senate Finance Committee Bill Addressing Drug Shortages Would Provide Long Overdue Relief from Penalties Hurting Generic Drug Market
  • Blog

Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram